Tripathy S - Search Results

1

Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice.

Tripathy S, Lytle KA, Stevens RD, Bain JR, Newgard CB, Greenberg AS, Huang LS, Jump DB. Tripathy S, et al. J Lipid Res. 2014 Jul;55(7):1448-64. doi: 10.1194/jlr.M050062. Epub 2014 May 9. J Lipid Res. 2014. PMID: 24814977 Free PMC article.

2

Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition.

Wang Y, Torres-Gonzalez M, Tripathy S, Botolin D, Christian B, Jump DB. Wang Y, et al. Among authors: tripathy s. J Lipid Res. 2008 Jul;49(7):1538-52. doi: 10.1194/jlr.M800123-JLR200. Epub 2008 Mar 30. J Lipid Res. 2008. PMID: 18376007 Free PMC article.

3

Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice.

Tripathy S, Torres-Gonzalez M, Jump DB. Tripathy S, et al. J Lipid Res. 2010 Sep;51(9):2642-54. doi: 10.1194/jlr.M006080. Epub 2010 May 19. J Lipid Res. 2010. PMID: 20488798 Free PMC article.

4

Omega-3 fatty acid supplementation and cardiovascular disease.

Jump DB, Depner CM, Tripathy S. Jump DB, et al. Among authors: tripathy s. J Lipid Res. 2012 Dec;53(12):2525-45. doi: 10.1194/jlr.R027904. Epub 2012 Aug 17. J Lipid Res. 2012. PMID: 22904344 Free PMC article. Review.

5

Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.

Tripathy S, Jump DB. Tripathy S, et al. J Lipid Res. 2013 Jan;54(1):71-84. doi: 10.1194/jlr.M028787. Epub 2012 Oct 24. J Lipid Res. 2013. PMID: 23099444 Free PMC article.

6

Fatty acid-regulated transcription factors in the liver.

Jump DB, Tripathy S, Depner CM. Jump DB, et al. Among authors: tripathy s. Annu Rev Nutr. 2013;33:249-69. doi: 10.1146/annurev-nutr-071812-161139. Epub 2013 Mar 22. Annu Rev Nutr. 2013. PMID: 23528177 Free PMC article. Review.

7

Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.

Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB. Depner CM, et al. Among authors: tripathy s. J Nutr. 2012 Aug;142(8):1495-503. doi: 10.3945/jn.112.158865. Epub 2012 Jun 27. J Nutr. 2012. PMID: 22739374 Free PMC article.

8

Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.

Jump DB, Depner CM, Tripathy S, Lytle KA. Jump DB, et al. Among authors: tripathy s. Proc Nutr Soc. 2016 Feb;75(1):1-9. doi: 10.1017/S002966511500244X. Epub 2015 Aug 18. Proc Nutr Soc. 2016. PMID: 26282529 Free PMC article.

9

Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.

Jump DB, Depner CM, Tripathy S, Lytle KA. Jump DB, et al. Among authors: tripathy s. Adv Nutr. 2015 Nov 13;6(6):694-702. doi: 10.3945/an.115.009423. Print 2015 Nov. Adv Nutr. 2015. PMID: 26567194 Free PMC article. Review.

10

Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.

Jump DB, Lytle KA, Depner CM, Tripathy S. Jump DB, et al. Among authors: tripathy s. Pharmacol Ther. 2018 Jan;181:108-125. doi: 10.1016/j.pharmthera.2017.07.007. Epub 2017 Jul 16. Pharmacol Ther. 2018. PMID: 28723414 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,475 results

Search Page

Filters